Cargando…

Generation of high-performance human cardiomyocytes and engineered heart tissues from extended pluripotent stem cells

Detalles Bibliográficos
Autores principales:	Li, Li, Wan, Zhongjun, Wang, Ruxiang, Zhao, Yuxin, Ye, Yida, Yang, Pengcheng, Qi, Yan, Jiang, Wei, Cai, Lin, Zhang, Donghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553887/ https://www.ncbi.nlm.nih.gov/pubmed/36220833 http://dx.doi.org/10.1038/s41421-022-00446-7

Ejemplares similares

Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues
por: Xu, He, et al.
Publicado: (2022)

Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
por: Goldfracht, Idit, et al.
Publicado: (2020)

Mechanotranduction Pathways in the Regulation of Mitochondrial Homeostasis in Cardiomyocytes
por: Liao, Hongyu, et al.
Publicado: (2021)

Electrospun Scaffolds and Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Engineering Applications
por: Suh, Taylor Cook, et al.
Publicado: (2020)

Intervertebral disc generation tissue engineering treatment platform: gelatin-methacryloyl hydrogel composite system
por: Hu, Yicun, et al.
Publicado: (2023)

Functional Properties of Engineered Heart Slices Incorporating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Blazeski, Adriana, et al.
Publicado: (2019)

Engineered heart tissue maturation inhibits cardiomyocyte proliferative response to cryoinjury
por: Ciucci, Giulio, et al.
Publicado: (2023)

Uses of cardiomyocytes generated from induced pluripotent stem cells
por: Lu, Tung-Ying, et al.
Publicado: (2011)

Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues
por: Cheng, Shangli, et al.
Publicado: (2023)

Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model
por: Sugiura, Tadahisa, et al.
Publicado: (2016)

Engineering human ventricular heart muscles based on a highly efficient system for purification of human pluripotent stem cell-derived ventricular cardiomyocytes
por: Li, Bin, et al.
Publicado: (2017)

De Novo Generation of Pulmonary Ionocytes from Normal and Cystic Fibrosis Human Induced Pluripotent Stem Cells
por: Wang, Ruobing, et al.
Publicado: (2023)

Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
por: Ge, Feixiang, et al.
Publicado: (2019)

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

Generation of human hepatocytes from extended pluripotent stem cells
por: Wang, Qiming, et al.
Publicado: (2020)

Encapsulation of Cardiomyocytes in a Fibrin Hydrogel for Cardiac Tissue Engineering
por: Ye, Kathy Yuan, et al.
Publicado: (2011)

Perspective on human pluripotent stem cell‐derived cardiomyocytes in heart disease modeling and repair
por: Li, Qiang, et al.
Publicado: (2020)

Epicardially secreted fibronectin drives cardiomyocyte maturation in 3D-engineered heart tissues
por: Ong, Lay Ping, et al.
Publicado: (2023)

Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells
por: Funakoshi, Shunsuke, et al.
Publicado: (2021)

Extended pluripotent stem cells facilitate mouse model generation
por: Xiang, Guanghai, et al.
Publicado: (2018)

Mitochondrial dysfunction by TFAM depletion disrupts self-renewal and lineage differentiation of human PSCs by affecting cell proliferation and YAP response
por: Qi, Yan, et al.
Publicado: (2022)

Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
por: James, Emma Claire, et al.
Publicado: (2021)

Generation of Functional Cardiomyocytes from Human Gastric Fibroblast-Derived Induced Pluripotent Stem Cells
por: Wu, Chih-Hsien, et al.
Publicado: (2021)

Qiliqiangxin Capsule Modulates Calcium Transients and Calcium Sparks in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Li, Yuxin, et al.
Publicado: (2022)

Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives
por: Chow, Maggie Zi, et al.
Publicado: (2013)

Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells
por: Hazeltine, Laurie B., et al.
Publicado: (2012)

Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications
por: Di Baldassarre, Angela, et al.
Publicado: (2018)

Derivation of feeder-free human extended pluripotent stem cells
por: Zheng, Ran, et al.
Publicado: (2021)

Derivation of feeder-free human extended pluripotent stem cells
por: Zheng, Ran, et al.
Publicado: (2021)

Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system
por: Xu, Junjun, et al.
Publicado: (2019)

Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
por: Giacomelli, E., et al.
Publicado: (2017)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

Protocol for the generation of blastocyst-like structures from mouse extended pluripotent stem cells
por: Li, Ronghui, et al.
Publicado: (2021)

Implementation of extended scope of practice
por: Harris, Jill
Publicado: (2013)

Memantine targets glutamate receptors in atrial cardiomyocytes to prevent and treat atrial fibrillation
por: Xie, Duanyang, et al.
Publicado: (2022)

Transferrin improved the generation of cardiomyocyte from human pluripotent stem cells for myocardial infarction repair
por: Zhang, Fengzhi, et al.
Publicado: (2020)

Single‐Cell Transcriptomics of Engineered Cardiac Tissues From Patient‐Specific Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome
por: Lam, Yin‐Yu, et al.
Publicado: (2020)

Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes
por: Jiang, Youxu, et al.
Publicado: (2022)

Investigating the effect of Shenmai injection on cardiac electrophysiology and calcium signaling using human-induced pluripotent stem cell-derived cardiomyocytes
por: Zhang, Zhang, et al.
Publicado: (2022)

Cardiac Tissue Engineering: Inclusion of Non-cardiomyocytes for Enhanced Features
por: Munawar, Sadek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3gu7or6ehb389g8oa8db5kak7u